Hydrogel Coatings for Enhanced Biomanufacturing of Cell Therapies

This invention delivers a transformative solution for biomanufacturing, enabling precise control over cell phenotypes and functions.

Technology

Biomanufacturing of cell-based therapies and cell-secreted factors is a critical area in therapeutic development. However, maintaining and directing the phenotype and function of cells during these processes remains a significant challenge. Traditional methods often rely on rigid substrates and soluble factors, which do not adequately mimic the natural cellular environment, leading to suboptimal therapeutic outcomes. This technology introduces a novel approach for forming hydrogel coatings that facilitate the modular display of various ligands, such as antibodies and proteins, while controlling the substrate’s biophysical properties like elasticity and viscoelasticity. The hydrogel model, is designed to replicate in vivo conditions more closely than existing rigid substrates.This system allows for precise modulation of cell activities, enhancing the production of cell therapies and cell-secreted factors under diverse conditions, including a temperature range of 4 to 40 degrees Celsius. This invention delivers a transformative solution for biomanufacturing, enabling precise control over cell phenotypes and functions. By mimicking natural cellular environments, we enhance therapeutic efficacy and streamline production processes, offering a scalable and adaptable platform for the next generation of cell-based therapies.

Benefits

  • Maintains and directs cellular activities during biomanufacturing, promoting desired cell phenotypes and functions.
  • Enhances CAR T cell activation and transduction, achieving higher therapeutic efficacy with reduced cell exhaustion.
  • Provides a soft, in vivo-like environment for cell culture, enhancing cellular function and therapy effectiveness.
  • Offers scalability and adaptability for various biomanufacturing workflows, supporting robust and efficient production processes.

Applications

  • Production of CAR T cell therapies with improved activation and transduction profiles.
  • Manufacturing of cell-secreted factors, such as extracellular vesicles and soluble proteins.
  • Potential expansion to other cell types and co-stimulatory domains for diverse therapeutic applications.